Half-Year Figures: ZEISS Looks back on Good First Six Months Overall

Half-year revenue reaches 3.2 billion euros (+6% compared to prior year) – EBIT at 455 million euros (+12 million euros compared to prior year) The Semiconductor Manufacturing Technology and Medical Technology segments contributed in particular to growth in the first six months Initial impact of the COVID-19 pandemic felt particularly in Q2 ZEISS portfolio ensures … Skaityti toliau

The Seimas approved the aid after quarantine: 1.4 million Lithuanians will benefit

The Seimas approved special aid and support measures for employees, the self-employed, people who lost their jobs and employers after quarantine. Most of these measures will be applied temporarily, until the country succeeds in recovering from the shock of the coronavirus pandemic. However, social benefits as well as reimbursement for heating costs will be increased … Skaityti toliau

Tour operators allowed to refund cancelled tours within six months

Press release, 9 April 2020  Under the special urgency procedure, the Seimas adopted amendments to the Law on Tourism and the Civil Code (draft laws No. XIIIP-4694(2) and No. XIIIP-4693(2)) allowing tour operators to refund cancelled tours not later than within six months, in contrast to a 14-day period applied so far. This provision will … Skaityti toliau

Half-Year Figures: ZEISS Innovations Help Achieve Strong Growth

OBERKOCHEN, 7 May 2019   The ZEISS Group had a successful end to the first six months of fiscal year 2018/19 (ended 31 March 2019) and saw its revenue rise by 9 percent to EUR 3.019 billion (1st six months of 2017/18: EUR 2.773 billion). At EUR 443 million, earnings before interest and tax (EBIT) were significantly … Skaityti toliau

AOP Orphan announces three-year results on Ropeginterferon alfa-2b in Polycythemia Vera at ASH

Vienna (pts046/03.12.2018/19:30) – * High rates of durable hematological response and symptom control with good tolerability were reconfirmed with Ropeginterferon alfa-2b after 36 months of treatment. * Disease Modification by Ropeginterferon alfa-2b was illustrated by high molecular response rates, associated with the ability to reduce allelic burden of both mutant JAK2 and importantly also non-JAK2 … Skaityti toliau

Seimas set out longer deadlines for holding a referendum

Press release, 28 September 2018    The Seimas adopted amendments to the Referendum Law (draft No XIIIP-2477(2)), thereby extending the period between the day of passing the Seimas Resolution on the date of calling a referendum and the day of conducting the referendum. Until now, the Referendum Law provided that a referendum is conducted “no later than in … Skaityti toliau

Seimas announced the dates for the 2019 elections

Press release, 25 September 2018    In its sitting, the Seimas endorsed its resolutions announcing the dates for the presidential, local and European Parliament elections. The local government elections are to be held on 3 March 2019, while the presidential election will take place on 12 May 2019 and the European Parliament elections in Lithuania … Skaityti toliau

Seimas specified regulations on the legal status of aliens studying in Lithuania

Press release, 31 May 2018    The Seimas amended the Law on the Legal Status of Aliens in order to implement the provisions of the Directive on the conditions of entry and residence of third-country nationals for the purposes of research, studies, training, voluntary service, pupil exchange schemes or educational projects and au pairing. The … Skaityti toliau

ZEISS Presents Half-Year Figures: High Tech Drives Growth

Revenue achieved in first half of fiscal year grows to EUR 2.8 billion – EBIT at prior-year level despite negative currency effects OBERKOCHEN, 18 MAY 2018 The first six months of fiscal year 2017/18 (ended 31 March 2018) were successful for the ZEISS Group and saw its revenue rise by 9 percent to EUR 2.773 … Skaityti toliau

500,000 New Biometric Driver's Licenses per Month

MANILA, Philippines, December 6 Exactly 3 months ago, Philippines’ Land Transport Office LTO started issuing its first new biometric driver’s licenses in Metro Manila. Now that the nationwide launch of the system has been successfully completed, LTO issues 500,000 licenses per month. DERMALOG, the German innovation leader in biometrics, supplied the cards and system. Assistant … Skaityti toliau